Maravai LifeSciences Holdings Inc (MRVI) Q3 2024 Earnings Call Highlights: Navigating ...

By Yahoo! Finance | Nov 8, 2024 at 02:37 AM EST

In Q4, the firm expects to fulfill $14 million of commitments. Factors influencing NAP revenue decline are project delays to 2025 and a weaker market. The acquisition for 2025 brings low single-digit million revenue and Q4 focuses on discovery business rates and potential drop-in orders.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.